A Clinical Study of APG-1387 in Combination With Entecavir in Patients With Chronic Hepatitis B
Clinical trial NCT04568265 · UNKNOWN
Trial details
- NCT number
- NCT04568265
- Sponsor
- Ascentage Pharma Group Inc.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-03
- Primary completion
- 2022-10-31
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.